The proposed existence of adult, marrow-derived stem cells that retain the ability to generate various tissues, is an appealing concept with considerable therapeutic potential. With few exceptions the data used to support this stem cell plasticity concept come from murine studies in which immune cytochemistry and molecular probes are used to identify rare donor cells in fixed tissue. Whether these observations are valid, and if valid, whether they pertain to larger longer lived animals remains controversial. To contribute to the resolution of this uncertainty we propose to investigate the contribution of marrow stem cells to skin, liver, and marrow stroma. We hypothesize that if """"""""plastic stem cells"""""""" reside in marrow they will contribute to nonhematopoietic tissue regeneration as needed. To test this we will investigate the effect of tissue specific proliferative demand on the detection of donor cells in canine stem cell recipients. All dogs used in these studies will be long term stable chimeras generated under the auspices of DK51 417. Briefly, under general anesthesia the chimeric dogs will undergo liver lobectomy, split skin harvest, and marrow aspiration. The harvested tissue will be assessed for % donor cells, the animals will recover, and after 3-5 months the regenerated tissue will also be assessed for % donor cells. Importantly tissue samples will be cultured ex vivo to expand cell populations of interest thereby providing relatively large numbers of morphologically distinct and cytochemically defined cells. Polymerase chain reaction (pcr) amplification of donor versus host DNA will then be used to determine the donor contribution to these defined cell populations. These strategies should improve the signal to noise ratio and make the detection of donor derived cells more reliable. The information gained should help define whether, and under what circumstances, marrow derived stem cells contribute to other tissues following allogeneic transplantation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK051417-08S1
Application #
6541565
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Badman, David G
Project Start
1995-09-30
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
8
Fiscal Year
2002
Total Cost
$152,240
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Kahl, Christoph; Mielcarek, Marco; Iwata, Mineo et al. (2004) Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation. Biol Blood Marrow Transplant 10:826-33
Junghanss, Christian; Takatu, Alessandra; Little, Marie-Terese et al. (2003) Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras. Transplantation 75:268-74
Kuhr, Christian S; Allen, Margaret D; Junghanss, Christian et al. (2002) Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras. Transplantation 73:1487-92
Zaucha, J M; Gooley, T; Bensinger, W I et al. (2001) CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transpla Blood 98:3221-7
Graf, L; Heimfeld, S; Torok-Storb, B (2001) Comparison of gene expression in CD34+ cells from bone marrow and G-CSF-mobilized peripheral blood by high-density oligonucleotide array analysis. Biol Blood Marrow Transplant 7:486-94
Zaucha, J M; Zellmer, E; Georges, G et al. (2001) G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required. Biol Blood Marrow Transplant 7:613-9
Iwata, M; Vieira, J; Byrne, M et al. (1999) Interleukin-1 (IL-1) inhibits growth of cytomegalovirus in human marrow stromal cells: inhibition is reversed upon removal of IL-1. Blood 94:572-8
Torok-Storb, B; Iwata, M; Graf, L et al. (1999) Dissecting the marrow microenvironment. Ann N Y Acad Sci 872:164-70
Mielcarek, M; Graf, L; Johnson, G et al. (1998) Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 92:215-22
Tanaka, J; Mielcarek, M; Torok-Storb, B (1998) Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells. Blood 91:347-52

Showing the most recent 10 out of 11 publications